ACB SUPPORTS OPT-IN BEFORE FINANCIAL INSTITUTIONS USE CONSUMERS’ PRIVATE MEDICAL INFORMATION
WASHINGTON, D.C. — America’s Community Bankers reaffirmed
its support today for a requirement that financial institutions obtain a
consumer’s permission before using private medical information in lending
decisions.
In a statement to the House Banking Committee, which conducted a
hearing on proposed medical privacy legislation, ACB said it continues to
support public policy that would require lenders to receive affirmative consent
from a consumer before individually identifiable health information can be
disclosed to another party.
ACB said the vast majority of its members do not have access to
customers’ medical information and do not seek such information in making loan
or credit decisions.
ACB said it supported the efforts of Committee Chairman Jim
Leach (R-Iowa) to include an opt-in requirement in last year’s
Gramm-Leach-Bliley Act, but Congress decided instead to wait until the U.S.
Department of Health and Human Services developed federal standards by
regulation. “We encourage Congress to refrain from passing additional
legislation before all currently authorized regulatory remedies, such as the
regulations being developed by HHS, are exhausted,” ACB said.
A copy of the statement is linked.
America’s Community Bankers is the national trade association committed to shaping the future of
banking by being the innovative industry leader strengthening the competitive position of
community banks. To learn more about ACB, visit
www.AmericasCommunityBankers.com.
-30-
|